Posted in | Hematology

Airway Management and Innovative Oxygenation

An update on techniques and the role of transcutaneous CO2 monitoring.

In this webinar, Dr. Huitink will discuss a current update of airway management assessment and techniques. He will also elaborate on the emerging role of transcutaneous CO2 monitoring in the operating theater.

Presenter

Dr. Johannes Huitink
Anesthesiologist at VU Medical Center Amsterdam, The Netherlands

Upon completion of his medical study at the VU University Medical Center in 1995, Johannes Huitink obtained a PhD in cardiology at the same center in the same year. He completed his anesthesiology training at the Academic Medical Center in Amsterdam in 2001. In that year he became staff anesthesiologist at the Department of Anesthesiology and Intensive Care Medicine at the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital in Amsterdam, where he specialized in cancer anesthesia.

In 2007, he moved to Australia and worked as staff consultant anesthetist at the Department of Anaesthesia and Pain Medicine of Western Health in Melbourne.

In 2008, he joined the Department of Anesthesiology at VU University Medical Center in Amsterdam, where he currently works and combines clinical work with teaching and research.

He is founder of the Airway Management Academy, member of the International Advisory Board of Anaesthesia Journal and member of the Difficult Airway Society and European Airway Management Society.

Who Should Attend?

  • Anesthesiologists
  • Intensivists
  • Emergency physicians

Other Webinars from Radiometer Medical

Medical Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.